27 results on '"Black, Donald M."'
Search Results
2. Association of high-density lipoprotein particle concentration with cardiovascular risk following acute coronary syndrome: A case-cohort analysis of the dal-Outcomes trial
3. Therapeutic targets in cardiovascular disease: a case for high-density lipoprotein cholesterol
4. A discussion of modalities for assessing regression and progression in vascular disease
5. Introduction
6. Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner
7. Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia
8. Aggressive lipid-lowering initiation abates new cardiac events (ALLIANCE)—rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease
9. Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia
10. Safety profile of atorvastatin-treated patients with low LDL-cholesterol levels
11. Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients
12. Treating patients with documented atherosclerosis to national cholesterol education program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin
13. Prostate cancer: New therapies in the pipeline?
14. Statins and fibrinogen
15. Efficacy and Safety in Phase II Trials
16. A Randomized Trial of the Effects of Atorvastatin and Niacin in Patients with Combined Hyperlipidemia or Isolated Hypertriglyceridemia
17. Rationale, Design, and Baseline Characteristics of a Trial Comparing Aggressive Lipid Lowering With Atorvastatin Versus Revascularization Treatments (AVERT) fn1fn1This work is supported by a grant from Parke-Davis Pharmaceutical Research, a Division of Warner-Lambert Company, Ann Arbor, Michigan.
18. Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels
19. Effectiveness of Atorvastatin for Reducing Low-Density Lipoprotein Cholesterol to National Cholesterol Education Program Treatment Goals
20. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels
21. The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study
22. Localization of the Human RNA Polymerase I Transcription Factor Gene (UBTF) to the D17S183 Locus on Chromosome 17q21 and Construction of a Long-Range Restriction Map of the Region
23. Molecular Cloning and Chromosomal Localization to 17q21 of the Human WNT3 Gene
24. Localization of a Second NM23 Gene, NME2, to Chromosome 17q21-q22
25. The search for the familial breast/ovarian cancer gene
26. Construction and regional localization of clones from a NotI linking library from human chromosome 17q
27. The Legal Implications of Dietary Fats: Risks of Cardiovascular Disease and the Duty of Food Manufacturers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.